Unnatural Products

Unnatural Products is a company that develops a macrocyclic drug discovery AI. It was founded in 2017 by Cameron Pye and Joshua Schwochert. Unnatural Products has received funding from Artis Ventures, Better Ventures, and Abstract Ventures. The company is based in Santa Cruz, California, United States.

Unnatural Products' AI develops macrocyclic drug compounds. The size of these compounds is larger than small-molecule drug compounds, yet their size allows them to bind with complex drug targets, such as antibodies. Macrocyclic structures are generally found in nature, but the company's AI is intended to generate synthetic versions of the structures, for use in drug development. The output from the AI is intended to develop oncological therapeutics. The AI is also meant to be used by pharmaceutical companies.